CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
IV compared to remdesivir IV alone for the treatment of symptomatic COVID-19 in severely immunocompromised adult participants who a...
Phase 3
San Diego, California, United States and 158 other locations
The main purpose of this study is to test an investigational drug known as VYD2311, which is being developed to lower the risk of getting COVID...
Phase 3
San Diego, California, United States and 19 other locations
This early-stage study will look at a new mRNA vaccine that combines defenses against both seasonal flu and COVID-19 in terms of it-...
Phase 1
San Diego, California, United States and 11 other locations
This is a pilot phase, open label, non-randomized study for the treatment of ARDS in patients infected with COVID-19. Subjects will...
Early Phase 1
Tijuana, Baja California, Mexico
vaccine for the prevention of symptomatic Coronavirus Disease 2019 (COVID-19).In order to represent a more recently circulating SAR...
Phase 2
Chula Vista, California, United States and 144 other locations
Researchers are looking for other ways to prevent severe illness from COVID-19. COVID-19 is a virus that most oft-...
Phase 3
San Diego, California, United States and 227 other locations
The purpose of the study is to evaluate whether ibuzatrelvir is effective and safe in adults and adolescents with COVID-19 who do n...
Phase 3
San Diego, California, United States and 262 other locations
the efficacy and safety of mRNA-1283 and mRNA-1273 (variant formulations) in adults 50 to 64 years of age without high risk factors for severe COVID...
Phase 4
San Diego, California, United States of America and 149 other locations
This Phase 2/3 study is a multi-portion design to confirm that the chosen formulation and dosing regimen of CoVLP has an acceptable immunogenicity an...
Phase 2, Phase 3
San Diego, California, United States and 91 other locations
The purpose of this study is to evaluate the effect of tozorakimab, as an add-on to SoC in patients with viral lung infection requiring supplemental...
Phase 3
Chula Vista, California, United States and 465 other locations
Clinical trials
Research sites
Resources
Legal